Inflammatory markers and blood pressure: Sex differences and the effect of fat mass in the CoLaus Study

Journal of Human Hypertension

Volumn 27, Issue 3, 2013, Pages 169-175

  Pruijm, M ^a   Vollenweider, P ^a   Mooser, V ^a   Paccaud, F ^b   Preisig, M ^a   Waeber, G ^a   Marques Vidal, P ^b   Burnier, M ^a   Bochud, M ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Blood pressure; C reactive protein; Interleukin 1 ; Interleukin 6; Population study; Tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FAT MASS; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSCILLOMETRY; PREVALENCE; PROTEIN BLOOD LEVEL; RANDOM SAMPLE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SWITZERLAND; SYSTOLIC BLOOD PRESSURE;

ADIPOSITY; ADULT; AGED; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; ELECTRIC IMPEDANCE; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SWITZERLAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874109400     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2012.12     Document Type: Article

References (40)

1. Androulakis ES, Tousoulis D, Papageorgiou N, Tsioufis C, Kallikazaros I, Stefanadis C. Essential hypertension: Is there a role for inflammatory mechanisms? Cardiol Rev 2009;17(5): 216-221
2. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA Study. Am J Hypertens 2004;17(7): 568-573
3. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-Alpha) and essential hypertension. J Hum Hypertens 2005;19(2): 149-154
4. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001;38(3): 399-403
5. Peeters AC, Netea MG, Janssen MC, Kullberg BJ, Van der Meer JW, Thien T. Proinflammatory cytokines in patients with essential hypertension. Eur J Clin Invest 2001;31(1): 31-36
6. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 2003;290(22): 2945-2951
7. Blake GJ, Rifai N, Buring JE, Ridker PM. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 2003;108(24): 2993-2999
8. Cheung BM, Ong KL, Tso AW, Leung RY, Xu A, Cherny SS et al. C-reactive protein as a predictor of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) cohort. J Hum Hypertens 2012;26(2): 108-116
9. Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A, Hayoz D et al. The CoLaus study: A population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 2008;8: 6
10. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995;311(6998): 158-161
11. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro III AF, Feldman HI et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150(9): 604-612
12. dupont NC, Wang K, Wadhwa PD, Culhane JF, Nelson EL. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: Determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 2005;66(2): 175-191
13. Elshal MF, McCoy JP. Multiplex bead array assays: Performance evaluation and comparison of sensitivity to ELISA. Methods 2006;38(4): 317-323
14. Fichorova RN, Richardson-Harman N, Alfano M, Belec L, Carbonneil C, Chen S et al. Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: A multicenter study. Anal Chem 2008;80(12): 4741-4751
15. Glass DC, Gray CN. Estimating mean exposures from censored data: Exposure to benzene in the Australian petroleum industry. Ann Occup Hyg 2001;45(4): 275-282
16. Newton-Cheh C, Hirschhorn JN. Genetic association studies of complex traits: Design and analysis issues. Mutat Res 2005;573(1-2): 54-69
17. Lakoski SG, Cushman M, Palmas W, Blumenthal R, D'Agostino Jr. RB, Herrington DM. The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2005;46(10): 1869-1874
18. Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 2003;16(6): 429-433
19. Wang L, Manson JE, Gaziano JM, Liu S, Cochrane B, Cook NR et al. Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women. Clin Chem 2011;57(5): 729-736
20. Wisse BE. The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004;15(11): 2792-2800
21. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factoralpha, in vivo. J Clin Endocrinol Metab 1997;82(12): 4196-4200
22. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 1990;7(2): 147-159
23. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282(22): 2131-2135
24. Carroll JF, Fulda KG, Chiapa AL, Rodriquez M, Phelps DR, Cardarelli KM et al. Impact of race/ethnicity on the relationship between visceral fat and inflammatory biomarkers. Obesity 2009;17(7): 1420-1427
25. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19(4): 972-978
26. Cartier A, Cô t M, Lemieux I, Pe'russe L, Tremblay A, Bouchard C et al. Sex differences in inflammatory markers: What is the contribution of visceral adiposity? Am J Clin Nutr 2009;89(5): 1307-1314
27. Colbert LH, Visser M, Simonsick EM, Tracy RP, Newman AB, Kritchevsky SB et al. Physical activity, exercise, and inflammatory markers in older adults: Findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc 2004;52(7): 1098-1104
28. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101(15): 1767-1772
29. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB et al. Long-Term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Med 2008;5(4): E78
30. Dalekos GN, Elisaf M, Bairaktari E, Tsolas O, Siamopoulos KC. Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: Additional risk factor for atherogenesis in hypertensive patients? J Lab Clin Med 1997;129(3): 300-308
31. Dalekos GN, Elisaf MS, Papagalanis N, Tzallas C, Siamopoulos KC. Elevated interleukin-1 beta in the circulation of patients with essential hypertension before any drug therapy: A pilot study. Eur J Clin Invest 1996;26(10): 936-939
32. Dewberry R, Holden H, Crossman D, Francis S. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20(11): 2394-2400
33. Ufnal M, Sikora M, Szczepanska-Sadowska E. Interleukin-1 receptor antagonist reduces the magnitude of the pressor response to acute stress. Neurosci Lett 2008;448(1): 47-51
34. Thorand B, Baumert J, Dö ring A, Herder C, Kolb H, Rathmann W et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006;184(1): 216-224
35. Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, Polak JF et al. Association of C-reactive protein with carotid atherosclerosis in men and women: The Framingham Heart Study. Arterioscler Thromb Vas Biol 2002;22(10): 1662-1667
36. Despres JP, Allard C, Tremblay A, Talbot J, Bouchard C. Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism 1985;34(10): 967-973
37. Khera A, Vega GL, Das SR, Ayers C, McGuire DK, Grundy SM et al. Sex differences in the relationship between C-reactive protein and body fat. J Clin Endocrinol Metab 2009;94(9): 3251-3258
38. Pottratz ST, Bellido T, Mocharla H, Crabb D, Manolagas SC. 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 1994;93(3): 944-950
39. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Despres JP. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 1993;58(4): 463-467
40. Gradmark AM, Rydh A, Renstrom F, De Lucia-Rolfe E, Sleigh A, Nordstrom P et al. Computed tomography-based validation of abdominal adiposity measurements from ultrasonography, dual-energy X-ray absorptiometry and anthropometry. Br J Nutr 2010;104(4): 582-588